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replicates damaged DNA
Abstract
A new gene (POLL), has been identified encoding the novel DNA polymerase lambda and mapped to
mouse chromosome 19 and at human chromosome 10. DNA polymerase lambda contains all the critical
residues involved in DNA binding, nucleotide binding, nucleotide selection, and catalysis of DNA
polymerization and has been assigned to family X based on sequence homology with polymerase beta,
lambda, mu, and terminal deoxynucleotidyltransferase. Here we describe a purification of DNA
polymerase lambda from calf thymus that preferentially can replicate damaged DNA. By testing
polymerase activity on non-damaged and damaged DNA, DNA polymerase lambda was purified trough
five chromatographic steps to near homogeneity and identified as a 67-kDa polypeptide that
cross-reacted with monoclonal antibodies against DNA polymerase beta and polyclonal antibodies
against DNA polymerase lambda. DNA polymerase lambda had no detectable nuclease activities and, in
contrast to DNA polymerase beta, was aphidicolin-sensitive. DNA polymerase lambda was a 6-fold
more accurate enzyme in an M13mp2 forward mutation assay and 5-fold more accurate in an
M13mp2T90 reversion system than human recombinant DNA polymerase beta. The biochemical
properties of the calf thymus DNA polymerase lambda, described here for the first time, are discussed in
relationship to the proposed role for this DNA polymerase in vivo.
DNA Polymerase  from Calf Thymus Preferentially Replicates
Damaged DNA*
Received for publication, January 15, 2002, and in revised form, March 5, 2002
Published, JBC Papers in Press, March 8, 2002, DOI 10.1074/jbc.M200421200
Kristijan Ramadan‡, Igor V. Shevelev‡§, Giovanni Maga¶, and Ulrich Hu¨bscher‡
From the ‡Institute of Veterinary Biochemistry and Molecular Biology, University of Zu¨rich-Irchel, Winterthurerstrasse
190, CH-8057, Zu¨rich, Switzerland, §Department of Molecular and Radiation Biophysics, Petersburg Nuclear Physics
Institute, Leningrad district, Gatchina, 188300, Russia, and ¶Istituto di Genetica Molecolare, Consislio Nationale
dell Ricerche, Via Abbiategrasso 207, I-27100, Pavia, Italy
A new gene (POLL), has been identified encoding the
novel DNA polymerase  and mapped to mouse chromo-
some 19 and at human chromosome 10. DNA polymerase
 contains all the critical residues involved in DNA bind-
ing, nucleotide binding, nucleotide selection, and catal-
ysis of DNA polymerization and has been assigned to
family X based on sequence homology with polymerase
, , , and terminal deoxynucleotidyltransferase. Here
we describe a purification of DNA polymerase  from
calf thymus that preferentially can replicate damaged
DNA. By testing polymerase activity on non-damaged
and damaged DNA, DNA polymerase  was purified
trough five chromatographic steps to near homogeneity
and identified as a 67-kDa polypeptide that cross-re-
acted with monoclonal antibodies against DNA polym-
erase  and polyclonal antibodies against DNA polymer-
ase . DNA polymerase  had no detectable nuclease
activities and, in contrast to DNA polymerase , was
aphidicolin-sensitive. DNA polymerase  was a 6-fold
more accurate enzyme in an M13mp2 forward mutation
assay and 5-fold more accurate in an M13mp2T90 rever-
sion system than human recombinant DNA polymerase
. The biochemical properties of the calf thymus DNA
polymerase , described here for the first time, are dis-
cussed in relationship to the proposed role for this DNA
polymerase in vivo.
Eukaryotic cells contain several DNA polymerases (pol)1
classified as classical pols (, , , , and ) and novel pols (, ,
, 	, 
, , , and ) (1). Novel pols have so far never been
purified directly from mammalian tissues.
Recombinant murine pol 
 (67 kDa) is a protein composed of
573 amino acids and is highly similar to the members of the pol
family X (2) comprising enzymes involved in the DNA repair
processes, whose main member is pol . The first 239 amino
acids of the N-terminal part of pol 
 with the exception of the
nuclear localization signal have no counterpart in pol . This
N-terminal part of pol 
 has similarity to yeast pol IV and
contains a BRCA1 C-terminal (BRCT) domain (2). The BRCT
domain is present in several proteins involved in DNA repair
and cell cycle checkpoint control (3, 4). Recently, it has been
shown that the BRCT domain is involved in protein/protein
interactions (4). The remaining part of pol 
 is composed of the
catalytic core, which is similar to pol  (8-kDa DNA deoxyribo-
phosphodiesterase domain and 32-kDa finger, palm, and
thumb-polymerization domain) and has 32% amino acid iden-
tity to pol  (2).
Pol 
 contains 5-deoxyribose phosphate lyase activity, but
no apurinic lyase activity (5), and can substitute pol  in in
vitro base excision repair (BER), suggesting that pol 
 partici-
pates in BER. Pol  is the main pol involved in the BER of
lesions generated by monofunctional alkylating agents in eu-
karyotic nuclear DNA, and pol 
 was proposed to be involved in
the other types of BER (5). However, understanding the possi-
ble physiological roles of this enigmatic pol would require a
complete characterization of the biochemical properties of the
endogenous enzyme. In this study, we describe, for the first
time, the isolation of endogenous pol 
 from a mammalian
tissue. Remarkably, this activity was isolated by an activity
assay that uses damaged DNA as a template, suggesting a
possible role of pol 
 in DNA repair and translesion synthesis.
MATERIALS AND METHODS
Chromatographic Media and Other Chemicals—Phosphocellulose
P11 was obtained from Whatman, hydroxyapatite from Bio-Rad, Hi-
Trap Desalting, HiTrap heparin, mono Q, and mono S columns from
Amersham Biosciences. Pepstatin, leupeptin, and aphidicolin were ob-
tained from Sigma. All other reagents were of analytical grade and
purchased from Merck or Fluka.
Buffers—All stock solutions were filtered through nitrocellulose before
use (0.45 m, Schleicher & Schu¨ll). The following buffers were used:
buffer 1 (50 mM Tris-HCl, pH 7.0, 50 mM NaCl, 20% (w/v) sucrose, 1 mM
DTT, 2 mM EDTA, 5 g/ml pepstatin, 1 g/ml leupeptin, 0.8 mM PMSF);
buffer 2 (50 mM Tris-HCl, pH 7.0, 50 mM NaCl, 1% (v/v) Triton X-100, 1
mM DTT, 2 mM EDTA, 5 g/ml pepstatin, 1 g/ml leupeptin, 0.8 mM
PMSF); buffer 3 (50 mM Tris-HCl, pH 7.0, 1 mM DTT, 2 mM EDTA, 10%
(v/v) glycerol, 5 g/ml pepstatin, 1 g/ml leupeptin, 0.8 mM PMSF, and
different molar concentrations of NaCl), buffer 4 (50 mM Tris-HCl, pH 7.0,
1 mM DTT, 2 mM EDTA, 10% (v/v) glycerol, 5 g/ml pepstatin, 1 g/ml
leupeptin, 0.8 mM PMSF, and different molar concentrations of potassium
phosphate); buffer 5 (50 mM Tris-HCl, pH 7.5, 1 mM DTT, 2 mM EDTA,
10% (v/v) glycerol, 5 g/ml pepstatin, 1 g/ml leupeptin, 0.8 mM PMSF,
and different molar concentrations of NaCl).
Preparation of Nucleic Acids—Amersham Biosciences was the sup-
plier of poly(dA) and oligo(dT)12–18. The homopolymer poly(dA) was
mixed to the oligomer oligo(dT)12–18 at a 10:1 base ratio in 20 mM Tris,
pH 8.0, 20 mM KCl, and 1 mM EDTA heated at 60 °C for 5 min with
subsequent slow cooling to room temperature.
Damaged (Apurinic) DNA Template Preparation and Characteriza-
tion—To create apurinic sites, the DNA template poly d(A)/oligo d(T) at
a 10:1 base ratio was incubated at a final concentration of 0.25 mg/ml at
70 °C in the following buffer: 10 mM sodium citrate, 10 mM NaCl, and 10
mM NaH2PO4, pH 5.2. This treatment specifically hydrolyzes the gly-
cosidic bond between the purine base and the deoxyribose moiety,
releasing the base without interrupting the continuity of the sugar-
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phosphate backbone. The degree of DNA damage was checked at dif-
ferent incubation times by monitoring the loss of DNA synthesis effi-
ciency by pols , , and . For the preparation of the apurinic poly(dA)/
oligo(dT) template, an incubation time of 40 min was selected,
corresponding to a loss of 80% DNA synthesis efficiency by pols  and 
and 73% by pol  if compared with the corresponding non-damaged
poly(dA)/oligo(dT).
Antibodies—The mouse monoclonal antibody against rat pol  pro-
tein was purchased from NeoMarkers (Freemont, CA). The rabbit poly-
clonal antibody against mouse pol 
 was a gift from L. Blanco (Madrid,
Spain).
DNA Polymerase Assays—A final volume of 25 l contained the
following components: 50 mM bis-Tris, pH 6.5, 1 mM DTT, 250 g/ml
bovine serum albumin, 6 mM MgCl2, 10 mM KCl, 20 M [
3H]dTTP, 0.5
g of poly(dA)/oligo(dT)12–18 (10:1 base ratio) or 0.1 g of depurinated
poly(dA)/oligo(dT)12–18 (10: 1 base ratio) and enzyme to be tested. 1 unit
of enzyme activity corresponds to the incorporation of 1 nmol of dTTP
into acid-precipitable material in 60 min at 37 °C.
Purification of a DNA Polymerase Activity That Preferentially Uses a
Damaged DNA Template—All enzymatic pol tests were performed with
poly d(A)/oligo (dT)12–18 or with damaged poly d(A)/oligo (dT)12–18, and
isolation steps were performed at or near 0 °C. 70 g of calf thymus were
resuspended in 210 ml of buffer 1 and homogenized in a Sorvall Omni-
mixer. After centrifugation in a GSA rotor at 12,000 rpm for 45 min, the
pellet was washed additionally in buffer 1. This pellet (35 g) was
resuspended in 140 ml of buffer 2, homogenized, rotated for 2 h, and
centrifuged at 12,000 rpm for 45 min. The supernatant (detergent
extract) was brought to pH 7.0 to yield fraction I. Fraction I was loaded
onto a 60-ml P11 phosphocellulose column, equilibrated previously in
buffer 3 with 50 mM NaCl. The column was first washed with 600 ml of
buffer 3 (50 mM NaCl), and the proteins were eluted with 500 ml of a
linear 50–700 mM gradient of NaCl in buffer 3. The peak fractions
containing pol activity on damaged DNA eluted between 220 and 300
mM NaCl and were pooled to yield fraction II. Fraction II was adsorbed
to a 6-ml hydroxyapatite column, equilibrated previously in buffer 4.
After washing with 10 column volumes of buffer 4 with 20 mM potas-
sium phosphate, a 10-column volume of a linear 20–500 mM potassium
phosphate gradient in buffer 4 was developed. On this column, separa-
tion of pols that do not synthesize on the damaged template was
achieved (see Fig. 1A). The pol activity on the damaged template was
eluted between 250 and 350 mM potassium phosphate, pooled, and
desalted to yield fraction III. Fraction III was loaded on a 1-ml HiTrap
heparin column equilibrated in buffer 3 (50 mM NaCl), the column was
washed with 6 ml of buffer 3 (50 mM NaCl), and the pol activity was
eluted with a 40-ml linear gradient of 50–1000 mM NaCl in buffer 3.
The active fractions were eluted between 550 and 650 mM NaCl, pooled,
and desalted to yield fraction IV. Fraction IV was loaded onto a fast
protein liquid chromatography mono Q column, equilibrated in buffer 5
(50 mM NaCl), washed with 5 ml of buffer 5 (50 mM NaCl), and eluted
with a 15-ml 50–1000 mM NaCl linear gradient in buffer 5. The active
FIG. 1. Purification of a 67-kDa DNA polymerase from calf thymus detergent extract that preferentially replicates damaged DNA.
A, flow chart of the purification procedure (for details, see “Materials and Methods”). F, fraction. B, chromatographic separation of a pol that is
preferentially active on damaged DNA from the classical pols. The second, minor peak (arrow, eluting between 250 and 350 mM potassium
phosphate) shows similar pol activity on non-damaged DNA and on damaged DNA. The specific activities were 7.6 units/mg on non-damaged DNA
and 5.1 units/mg on damaged DNA. The pooled fractions 12–17 were used for further purification. C, the last chromatography step, the mono S
column. The pol activity eluted between 350 and 300 mM NaCl on mono S column as one peak. The pol activity was 2064 units/mg on damaged DNA
versus 1040 units/mg on non-damaged DNA (details of chromatographic behavior are described under “Materials and Methods”). D, fractions V and
VI analyzed in a 12.5% SDS-polyacrylamide gel electrophoresis and stained with Coomassie Brilliant Blue. Only one band at a position of 67 kDa
was identified in fraction VI. MWM, molecular weight markers.
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fractions were eluted between 380 and 500 mM NaCl, pooled, and
desalted to yield fraction V. Fraction V was loaded onto a fast protein
liquid chromatography mono S column, equilibrated in buffer 5 (50 mM),
and washed with 5 ml of buffer 5 (50 mM NaCl). The pol activity was
eluted with a 10-ml 50–500 mM linear gradient in buffer 5 as a homo-
geneous peak. The active fractions were immediately frozen in small
aliquots to 80 °C until further use.
Fidelity Assay—Bacteriophage M13mp2 and Escherichia coli strains
CSH50, NR9099, and MC1061 were as described in Ref. 6. Nonsense
mutant M13mp2T90 (point mutation G:T in the position90 of the lacZ
gene) was selected after sequencing analysis of colorless mutants as a
mutation hot point in the DNA M13mp forward mutation assay. The
sequence of the 26-mer oligonucleotide was: 5-cga tta agt tgg gta acg
cca ggg tt-3. This oligonucleotide was hybridized in addition to the gap
molecules (the 3-end of the primer being located as three nucleotides
from the point substitution T in the nonsense mutant instead of G in
M13mp2 DNA at position 90 of lacZ gene) to verify that in every case,
the nucleotides were incorporated in the nonsense codon TAA. Forward
and reverse mutation assays were done according to Ref. 6. Replication
reactions for the forward mutation assay were carried out for 2 h at
37 °C in 10 l containing: 5 mM MgCl2, 50 mM Tris-HCl, pH 7.2, 1 mM
DTT, 100 g/ml bovine serum albumin, 40 ng of gapped circular
M13mp2 DNA, 20 M each of dATP, dCTP, dGTP, and dTTP, and 0.03
units of either pol 
 or pol . In this case, about 250–300 nucleotides
were incorporated per DNA template, although for calculation of the
error rate, it was necessary to fill 250 nucleotides of 350 gapped.
Replication reactions for the reverse mutation assay were carried out
for 10 min by using as a template M13mp2T90 DNA with an additional
26-mer oligonucleotide. All other conditions were identical to the for-
ward mutation assay.
Other Methods—The following three methods were carried out ac-
cording to established protocols: SDS-PAGE (7), immunoblotting (8),
and in situ polymerase activity gel analysis (9).
RESULTS AND DISCUSSION
Purification of a 67-kDa DNA Polymerase from Calf Thymus
Detergent Extract That Preferentially Replicates Damaged
DNA—Calf thymus detergent extract was fractionated using a
damaged DNA as the template for measuring DNA polymerase
activity (see “Materials and Methods”), and DNA polymerase
activity was monitored through different chromatographic
steps (Fig. 1A). On the second purification step, a peak eluting
between 250 and 350 mM potassium phosphate, which had a
similar activity on both the non-damaged and damaged DNA,
was separated by the bulk of DNA polymerase activity (Fig.
1B). This activity was then purified through HiTrap Heparin-
Sepharose, mono Q and mono S columns. The resulting peak
fractions (Fig. 1C) were analyzed on SDS-PAGE and showed a
single band of 67 kDa (Fig. 1D).
Identification of the 67-kDa DNA Polymerase as DNA Polym-
erase 
—The final mono S fraction (fraction VI) was analyzed
by immunoblot for a variety of known pols, such as pols , , ,
and . No bands were observed with antibodies against pols ,
, and  (data not shown), but a strong signal was discovered for
a 67-kDa polypeptide with a monoclonal antibody against hu-
man recombinant pol  (Fig. 2A), suggesting that we had iso-
lated a -like pol. Next, the same mono S fraction was tested
with an antibody against pol 
, and a clear signal was again
obtained for this polypeptide (Fig. 2B). All pols of family X have
very conserved DNA polymerase domains (2); therefore, the
cross-reactivity of pol 
 with pol  antibody was not unex-
pected. Next, we tested whether this 67-kDa polypeptide was
responsible for the polymerase activity. As shown in Fig. 2C, in
situ activity gel analysis showed that the polypeptide corre-
sponding to the 67-kDa band was able to incorporate nucleo-
FIG. 2. Identification of the 67-kDa polypeptide as pol . A,
fractions (F) V and VI (see panel A of Fig. 1) immunoblotted after 12.5%
SDS-polyacrylamide gel electrophoresis with monoclonal antibodies
against pol . The pol  antibody cross-reacted with a band at position
67 kDa in both fractions. The recombinant pol  was used as a positive
control. MWM, molecular weight markers. B, immunoblot analysis for
pol 
. Polyclonal antibodies against pol 
 cross-reacted with a 67-kDa
polypeptide in both fractions V and VI. C, activity gel analysis per-
formed to confirm the pol activity in the 67-kDa polypeptide. Fraction
VI and pol  were tested in a 12% SDS-PAGE activity gel analysis as
described under “Materials and Methods.”
FIG. 3. Biochemical properties of calf thymus DNA polymerase
. All pol 
 assays were performed as described under “Materials and
Methods.” 100% of activity corresponds to 21 units/ml on damaged
DNA. A, dependence of activity on divalent cations. F, fraction. B,
dependence of the activity on the pH in different buffer systems. C,
sensitivity of polymerase activity to aphidicolin. DNA pol 
 was inhib-
ited by aphidicolin (big squares). DNA pol  was used in the same
experiment as a control for aphidicolin resistance (small squares). D,
dependence of reaction velocity on dTTP concentration. Curves were
fitted to the experimental points by non-linear least squares fitting.
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tides into a DNA template. These data strongly suggested that
the pol isolated from calf thymus using a damaged DNA as the
template is pol 
. Accordingly, only pol 
 among family X pols
has an expected molecular mass of 64–67 kDa based on the
cDNA sequence of human and mouse.
It has been reported that N-terminal domain of pol 
 shares
similarity with yeast pol IV and that the C-terminal domain
shares similarity with mammalian pol  (2). Although yeast pol
IV shows the properties typical for pol , the apparent molec-
ular mass of the polypeptide is larger (68 kDa) (10). Therefore,
it is possible that pol 
, rather than pol , is the homolog of
yeast pol IV.
Biochemical Properties of DNA Polymerase 
—Since the pol
activity after the last mono S column was low, an optimization
and characterization was performed. These are summarized in
Fig. 3. The pH optimum of pol 
 was 6.5 with 50 mM bis-Tris,
Tris-HCl, or 15 mM potassium phosphate buffers. The Mg2
optimum was 1.5 mM, and for Mn2, it was 0.5 mM. The Km for
the nucleotide substrate (dTTP) was 5.9 M, and the Vmax was
0.38 pmol/min. The ratio Vmax/Km was 2.57  10
3 min1  1
l1, which is a lower estimation of kcat/Km. These results are
significantly different from those for human recombinant pol 
,
which has low Km (0.5 M) for the nucleotide substrate and
optimal conditions for pol activity at pH 7.5 and 10 mM MgCl2
(11). Pol  is resistant to inhibition by aphidicolin (10, 12);
therefore, it was interesting to examine the purified calf thy-
mus pol 
 for this inhibitor. Unexpectedly and in contrast to pol
, pol 
 was aphidicolin-sensitive.
Fidelity of DNA Polymerases 
 and  in a Forward and in a
Reverse Mutation Assay—Pol  is the least accurate classical
mammalian pol, with an average substitution error rate of
about 103 (13). Human recombinant pol  (a member of family
X DNA polymerases) is an error-prone pol (14). Replication
fidelity of natural pol 
 has never been measured before. There-
fore, we compared the fidelity of calf thymus pol 
 with human
recombinant pol . A 6-fold more accurate synthesis was ob-
served for pol 
 as compared with pol  in a forward mutation
assay (Table I) when both base substitution and frameshift
mutation were determined. We have used 2-h gap filling reac-
tions. Under these conditions, even if neither a 335 exonu-
clease nor any other nuclease was identified in pol 
 fractions,
a very minor proofreading activity could influence the overall
fidelity due to a long incubation. To exclude this probability
and estimate a share of base substitutions from total errors, we
used the additional reverse mutation system on M13mp2T90
DNA with only a 10-min synthesis (see “Materials and Meth-
ods”). The data from Table II confirmed a 5-fold higher fidelity
of pol 
 as compared with pol . Errors can occur during any
DNA synthesis reaction in a cell, including the gap filling
synthesis required for mismatch repair, BER, or nucleotide
excision repair. These repair processes require different
amounts of DNA resynthesis, catalyzed by pols having very
different error rates. The main repair pol  has an average
substitution error rate of about 103. If this was the error rate
in vivo, only BER-associated synthesis of pol  would yield
about 10 errors per day (15). However, the fidelity of a complete
BER complex must be higher than that of the pol alone. It was
shown that pol  misinsertion might be proofread by an extrin-
sic exonuclease (16, 17) or subsequently corrected by some
forms of DNA mismatch repair. Furthermore, it was shown
that an alternative BER pathway can utilize pols  and . Using
nuclear extracts from wild-type and -pol null mouse fibro-
blasts, it has been demonstrated that this alternative BER
pathway has a repair patch size of about two to six nucleotides
(18). We have identified pol 
 from calf thymus as a pol activity
scoring better on damaged versus non-damaged DNA. The facts
that pol 
 can incorporate nucleotides on damaged DNA and
has 5- to 6-fold higher fidelity than pol  suggest that pol 
 can
contribute substantially to DNA repair. Thus, based on our
results, we suggest that pol 
 could be responsible for this
additional long patch BER pathway. It was shown recently that
human recombinant pol 
 performs a limited but significant
strand displacement synthesis on gapped DNA substrates, a
capacity that would be essential to allow the participation of
pol 
 in long patch BER (5). It was also shown that human
recombinant pol 
 exhibits 5-deoxyribose phosphate lyase ac-
tivity and, in coordination with its polymerization activity,
efficiently repaired uracil-containing DNA in an in vitro recon-
stituted BER reaction. Thus, pol 
 may participate in single-
nucleotide BER in mammalian cells. The mRNA for human pol

 was highly abundant in testis, although basal levels were
detected in all tissues examined (2). Therefore, and in addition
to demonstrating its putative role in meiotic recombination, it
will be relevant to determine whether pol 
 could also have a
TABLE II
Mutation frequencies of DNA polymerases 
 and  by the reverse mutation assay
Pol Totalplaques
Revertant
plaques
Mutation
frequency Error rate
a
 105
none 300,000 4 1.3
pol 
 71,000 10 14.1 1/11,700
pol  24,400 17 68.3 1/2,200
a The error rate in each case was calculated by the next subtracting the background (4.2  104) from the mean of the mutant frequency (for
pol  480.0  104), dividing by 0.5 (the approximate probability of expressing error), and then dividing by the number of sites (110), yielding an
average error rate of 1/1,200 nucleotides (for pol ). In the reverse mutation assay, the background was 1.3 105, and the frequency was therefore
divided by 3 to correct for the number of sites in the nonsense codon target.
TABLE I
Mutation frequencies of DNA polymerases 
 and  by the forward mutation assay
Pol Totalplaques
Mutant
plaques
Mutation
frequency Error rate
a
 104
none 12,000 5 4.2
pol 
 3,000 23 76.7 1/7,600
pol  2,000 96 480.0 1/1,200
a The error rate in each case was calculated by the next subtracting the background (4.2  104) from the mean of the mutant frequency (for
pol  480.0  104), dividing by 0.5 (the approximate probability of expressing error), and then dividing by the number of sites (110), yielding an
average error rate of 1/1,200 nucleotides (for pol ). In the reverse mutation assay, the background was 1.3 105, and the frequency was therefore
divided by 3 to correct for the number of sites in the nonsense codon target.
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role in homologous recombination (e.g. repair of double-
stranded breaks, a process contributing to genetic stability in
somatic cells).
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